VCN-01
2 clinical trials
1 abstract
4 indications
Indication
RetinoblastomaIndication
RecurrentIndication
Pancreatic CancerIndication
Ovarian CancerAbstract
VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.Org: Vall d´Hebrón Institute of Oncology (VHIO),
Clinical trial
Phase I Study, Single Site, Open Label With Dose Escalation, for Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory RetinoblastomaStatus: Active (not recruiting), Estimated PCD: 2024-06-15
Clinical trial
Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination With VCN-01 in Patients With Pancreatic and Serous Epithelial Ovarian CancerStatus: Recruiting, Estimated PCD: 2038-09-01